Shire rises on Astrazenca bid talk: traders
LONDON (Reuters) - Shares in Shire (SHP.L) gained 2.3 percent in brisk volume on Wednesday, bucking a weaker European stock market, with traders citing rehashed talk of a potential bid from UK-listed pharmaceutical peer AstraZeneca (AZN.L).
Shire's stock had traded 70 percent of its full-day volume average at 1341 GMT and it was among the top risers on the pan-European FTSEurofirst 300 index .FTEU3, down 0.3 percent.
AstraZeneca said it did not comment on market rumours, while Shire was unavailable for comment.
(Written by David Brett; Editing by Francesco Canepa)
- Tweet this
- Share this
- Digg this
FRANKFURT - New solar installations reached a fresh record of 7.5 gigawatts (GW) in Germany in 2011, playing into the hands of advocates for steeper cuts in tariff subsidies to reduce growth of solar power and the resulting higher costs for consumers.